Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05823090 · ClinicalTrials.gov registry record · Phase 4
Light Therapy for Depression in Adolescent Outpatients
A Phase 4 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Completed
- Registry status
- Phase 4
- Development phase
- 9
- Enrollment target
NCT05823090 is a Phase 4 study that has completed, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 9 participants.
The verdict
NCT05823090, a Phase 4 study, has completed, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 9 participants
- Enrollment target
Study Summary
The goal of this placebo lead-in clinical trial was to test bright light therapy (BLT) in adolescents with depression. The main question\[s\] it aimed to answer were: 1. characterize and define facilitators/barriers to treatment with BLT in adolescents); 2. evaluate the acceptability and feasibility of outpatient BLT in a dose titration protocol; 3. establish an effective, safe and tolerable light dose.
Interventions
- DEVICE light box (Carex DayLight Classic Model)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2021-12-21 |
| Est. Completion | 2022-11-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05823090
The ClinicalTrials.gov registry entry for NCT05823090 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which light box (Carex DayLight Classic Model) is the first listed.
NCT05823090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05823090 about?
NCT05823090 is a clinical study titled "Light Therapy for Depression in Adolescent Outpatients". The goal of this placebo lead-in clinical trial was to test bright light therapy (BLT) in adolescents with depression. The main question\[s\] it aimed to answer were: 1. characterize and define facilitators/barriers to treatment with BLT in adolescents); 2. evaluate the acceptability and feasibilit...
What is the current status of trial NCT05823090?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 9 participants. The study started on 2021-12-21. Estimated completion is 2022-11-08.
What interventions are being tested in trial NCT05823090?
The interventions under investigation include: light box (Carex DayLight Classic Model) (DEVICE).
Who is sponsoring clinical trial NCT05823090?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.